UK markets closed

Cigna Corporation (CI)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
260.05+3.47 (+1.35%)
As of 02:15PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 80.05B
Enterprise value 105.22B
Trailing P/E 12.65
Forward P/E 10.91
PEG ratio (5-yr expected) 0.99
Price/sales (ttm)0.47
Price/book (mrq)1.78
Enterprise value/revenue 0.58
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.68
52-week change 35.34%
S&P500 52-week change 3-13.08%
52-week high 3340.11
52-week low 3239.50
50-day moving average 3293.55
200-day moving average 3294.14

Share statistics

Avg vol (3-month) 31.66M
Avg vol (10-day) 32.04M
Shares outstanding 5297.03M
Implied shares outstanding 6N/A
Float 8295.43M
% held by insiders 11.55%
% held by institutions 190.69%
Shares short (27 Feb 2023) 42.7M
Short ratio (27 Feb 2023) 41.55
Short % of float (27 Feb 2023) 40.91%
Short % of shares outstanding (27 Feb 2023) 40.91%
Shares short (prior month 30 Jan 2023) 42.1M

Dividends & splits

Forward annual dividend rate 44.92
Forward annual dividend yield 41.80%
Trailing annual dividend rate 34.48
Trailing annual dividend yield 31.75%
5-year average dividend yield 40.54
Payout ratio 421.03%
Dividend date 322 Mar 2023
Ex-dividend date 406 Mar 2023
Last split factor 23:1
Last split date 304 Jun 2007

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022

Profitability

Profit margin 3.70%
Operating margin (ttm)4.43%

Management effectiveness

Return on assets (ttm)3.34%
Return on equity (ttm)14.64%

Income statement

Revenue (ttm)180.02B
Revenue per share (ttm)581.57
Quarterly revenue growth (yoy)-0.00%
Gross profit (ttm)22.98B
EBITDA 9.84B
Net income avi to common (ttm)6.67B
Diluted EPS (ttm)20.04
Quarterly earnings growth (yoy)4.70%

Balance sheet

Total cash (mrq)6.76B
Total cash per share (mrq)22.76
Total debt (mrq)31.55B
Total debt/equity (mrq)70.19
Current ratio (mrq)0.73
Book value per share (mrq)150.24

Cash flow statement

Operating cash flow (ttm)8.66B
Levered free cash flow (ttm)10.26B